GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q BioMed Inc (OTCPK:QBIO) » Definitions » ROIC %

Q BioMed (Q BioMed) ROIC % : -23.34% (As of Feb. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Q BioMed ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Q BioMed's annualized return on invested capital (ROIC %) for the quarter that ended in Feb. 2023 was -23.34%.

As of today (2024-05-23), Q BioMed's WACC % is 0.00%. Q BioMed's ROIC % is 0.00% (calculated using TTM income statement data). Q BioMed earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Q BioMed ROIC % Historical Data

The historical data trend for Q BioMed's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q BioMed ROIC % Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,804.00 -382.54 -628.20 -379.41 -62.38

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -131.41 -91.16 -70.69 -37.83 -23.34

Competitive Comparison of Q BioMed's ROIC %

For the Biotechnology subindustry, Q BioMed's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q BioMed's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q BioMed's ROIC % distribution charts can be found below:

* The bar in red indicates where Q BioMed's ROIC % falls into.



Q BioMed ROIC % Calculation

Q BioMed's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Nov. 2022 is calculated as:

ROIC % (A: Nov. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Nov. 2021 ) + Invested Capital (A: Nov. 2022 ))/ count )
=-3.446 * ( 1 - 0% )/( (3.403 + 7.645)/ 2 )
=-3.446/5.524
=-62.38 %

where

Q BioMed's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Feb. 2023 is calculated as:

ROIC % (Q: Feb. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2022 ) + Invested Capital (Q: Feb. 2023 ))/ count )
=-1.78 * ( 1 - 0% )/( (7.645 + 7.606)/ 2 )
=-1.78/7.6255
=-23.34 %

where

Note: The Operating Income data used here is four times the quarterly (Feb. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q BioMed  (OTCPK:QBIO) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Q BioMed's WACC % is 0.00%. Q BioMed's ROIC % is 0.00% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Q BioMed ROIC % Related Terms

Thank you for viewing the detailed overview of Q BioMed's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Q BioMed (Q BioMed) Business Description

Traded in Other Exchanges
N/A
Address
C/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biomedical acceleration and development company. It has a focus on licensing, acquiring, and providing strategic resources to life sciences and healthcare companies. The company intends to mitigate risk by acquiring multiple assets over time and across a broad spectrum of healthcare-related products, companies, and sectors. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. It also has three development-stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma.
Executives
William S Rosenstadt director, 10 percent owner, officer: Chief Legal Officer ORTOLI ROSENSTADT LLP, 501 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022
Denis Corin director, 10 percent owner, officer: Chief Executive Officer 10 MARKET STREET, SUITE 427, GRAND CAYMAN E9 KY1-9006
Rick Panicucci director 501 MADISON STREET, 14TH FLOOR, NEW YORK NY 10022
Alan P Lindsay 10 percent owner 580 HORNBY STREET, FIFTH FLOOR, VANCOUVER BC CANADA V6C 2E7 A1